BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7952035)

  • 1. Determination of orally administered all-trans-retinoic acid in human plasma by high-performance liquid chromatography.
    Guiso G; Rambaldi A; Dimitrova B; Biondi A; Caccia S
    J Chromatogr B Biomed Appl; 1994 Jun; 656(1):239-44. PubMed ID: 7952035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
    Muindi JR; Frankel SR; Huselton C; DeGrazia F; Garland WA; Young CW; Warrell RP
    Cancer Res; 1992 Apr; 52(8):2138-42. PubMed ID: 1559217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in the oral bioavailability of all-trans-retinoic acid.
    Adamson PC; Pitot HC; Balis FM; Rubin J; Murphy RF; Poplack DG
    J Natl Cancer Inst; 1993 Jun; 85(12):993-6. PubMed ID: 8388479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of all-trans and 13-cis retinoic acids and their 4-oxo metabolites by adsorption liquid chromatography after solid-phase extraction.
    Lefebvre P; Agadir A; Cornic M; Gourmel B; Hue B; Dreux C; Degos L; Chomienne C
    J Chromatogr B Biomed Appl; 1995 Apr; 666(1):55-61. PubMed ID: 7655621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.
    Rigas JR; Francis PA; Muindi JR; Kris MG; Huselton C; DeGrazia F; Orazem JP; Young CW; Warrell RP
    J Natl Cancer Inst; 1993 Dec; 85(23):1921-6. PubMed ID: 8230282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
    Lefebvre P; Thomas G; Gourmel B; Agadir A; Castaigne S; Dreux C; Degos L; Chomienne C
    Leukemia; 1991 Dec; 5(12):1054-8. PubMed ID: 1774953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.
    Adamson PC; Bailey J; Pluda J; Poplack DG; Bauza S; Murphy RF; Yarchoan R; Balis FM
    J Clin Oncol; 1995 May; 13(5):1238-41. PubMed ID: 7738627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
    Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
    Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel inhibition of cis/trans retinoic acid interconversion in biological fluids--an accurate method for determination of trans and 13-cis retinoic acid in biological fluids.
    Wang CJ; Pao LH; Hsiong CH; Wu CY; Whang-Peng JJ; Hu OY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):283-91. PubMed ID: 14581068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isocratic reversed-phase liquid chromatography of all-trans-retinoic acid and its major metabolites in new potential supplementary test systems for developmental toxicology.
    Dimitrova B; Poyrè M; Guiso G; Badiali A; Caccia S
    J Chromatogr B Biomed Appl; 1996 May; 681(1):153-60. PubMed ID: 8798924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia.
    Schwartz EL; Hallam S; Gallagher RE; Wiernik PH
    Biochem Pharmacol; 1995 Sep; 50(7):923-8. PubMed ID: 7575674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.
    Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
    J Nutr Sci Vitaminol (Tokyo); 1995 Aug; 41(4):493-8. PubMed ID: 8676222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of endogenous levels of 13-cis-retinoic acid (isotretinoin), all-trans-retinoic acid (tretinoin) and their 4-oxo metabolites in human and animal plasma by high-performance liquid chromatography with automated column switching and ultraviolet detection.
    Wyss R; Bucheli F
    J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):31-47. PubMed ID: 9390712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
    Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia.
    Usuki K; Endo M; Osawa M; Kitazume K; Iki S; Urabe A
    Int J Hematol; 1996 Jan; 63(1):19-23. PubMed ID: 8713573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detection.
    Wu C; Njar V; Brodie A; Borenstein M; Nnane I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):203-8. PubMed ID: 15380716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved quantitation of 13-cis- and all-trans-acitretin in human plasma by normal-phase high-performance liquid chromatography.
    Meyer E; Lambert WE; De Leenheer AP; Bersaques JP; Kint AH
    J Chromatogr; 1991 Sep; 570(1):149-56. PubMed ID: 1839158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 13-cis-retinoic acid and its major metabolite, 4-oxo-13-cis-retinoic acid, in human blood by reversed-phase high-performance liquid chromatography.
    Vane FM; Stoltenborg JK; Buggé CJ
    J Chromatogr; 1982 Feb; 227(2):471-84. PubMed ID: 6460777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of all-trans-, 13-cis-, 9-cis-retinoic acid and their 4-oxo-metabolites in plasma by high-performance liquid chromatography.
    Disdier B; Bun H; Catalin J; Durand A
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):143-54. PubMed ID: 8891911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low plasma level of all-trans retinoic acid after feeding tube administration for acute promyelocytic leukemia.
    Takitani K; Nakao Y; Kosaka Y; Inoue A; Kawakami C; Kuno T; Tamai H
    Am J Hematol; 2004 May; 76(1):97-8. PubMed ID: 15114613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.